Results 101 to 110 of about 3,332 (178)

Studies on the role of autoantibodies and autoantigens in rheumatoid arthritis and myositis [PDF]

, 2016
A major population of patients affected with rheumatoid arthritis (RA) and inflammatory idiopathic myopathies (IIM, collectively called myositis) is characterized by the presence of autoantibodies.
Cerqueira, Cátia
core   +1 more source

Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma [PDF]

, 2017
Hanna Lythgoe, Eileen Baildam, Michael W. Beresford, Gavin Cleary, Liza McCann, Clare Pain   +5 more
openalex   +1 more source

A Partnership for Health: Minorities & Biomedical Research [PDF]

, 2003
The National Institute of Allergy and Infectious Diseases (NIAID) has long recognized that minority populations bear a disproportionate burden of sickness and disease in the United States.

core  

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

A Scoping Review of the Efficacy and Safety of Methotrexate Compared to Mycophenolate Mofetil in the Treatment of Juvenile Localized Scleroderma in Children and Young Adults [PDF]

, 2023
Shabnam Singhal, Eleanor Heaf, Joanne L. Jordan, Nadia Corp   +3 more
openalex   +1 more source

Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre [PDF]

, 2020
Background: Linear morphoea is a severe morphoea subtype associated with extracutaneous manifestations, potentially permanent disfigurement and functional impairment.
Denton, CP, George, C, Nihtyanova, SI, Saracino, AM   +3 more
core  

Abstract

JPGN Reports, Volume 6, Issue S2, Page S1-S814, September 2025.
wiley   +1 more source

The Importance of the Skin Syndrome in the Primary Diagnosis of Connective Tissue Diseases in Children: Case Report

Педиатрическая фармакология
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible
Anastasia O. Zatolokina, Tamara V. Belousova, Svetlana A. Loskutova, Nataliya E. Blagitko   +3 more
doaj   +1 more source

Recent Advances in Localized Scleroderma

Sclerosis
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi, Takehiro Takahashi, Yoshihide Asano   +2 more
doaj   +1 more source

42086 Disease Course and Risk of Relapse in Juvenile Localized Scleroderma [PDF]

, 2023
Merna Adly, Brian D. Rankin, Abrahim Abduelmula, Brendan Cord Lethebe, E M Milovanova, Rebeka Stevenson, Vimal H. Prajapati, Nadia Luca   +7 more
openalex   +1 more source